Cargando…
α(1)-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer’s Disease
α(1)-Adrenergic receptors (ARs) are members of the G-Protein Coupled Receptor superfamily and with other related receptors (β and α(2)), they are involved in regulating the sympathetic nervous system through binding and activation by norepinephrine and epinephrine. Traditionally, α(1)-AR antagonists...
Autor principal: | Perez, Dianne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963459/ https://www.ncbi.nlm.nih.gov/pubmed/36835598 http://dx.doi.org/10.3390/ijms24044188 |
Ejemplares similares
-
Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure
por: Perez, Dianne M.
Publicado: (2021) -
α(1)-Adrenergic Receptors in Neurotransmission, Synaptic Plasticity, and Cognition
por: Perez, Dianne M.
Publicado: (2020) -
Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer’s Disease
por: Frost, Miles, et al.
Publicado: (2020) -
Current Developments on the Role of α(1)-Adrenergic Receptors in Cognition, Cardioprotection, and Metabolism
por: Perez, Dianne M.
Publicado: (2021) -
Sympatho-adrenergic mechanisms in heart failure: new insights into pathophysiology
por: Du, Xiaojun
Publicado: (2021)